214 related articles for article (PubMed ID: 26716992)
1. The INNs and outs of antibody nonproprietary names.
Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
[TBL] [Abstract][Full Text] [Related]
2. Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more.
Parren PWHI; Carter PJ; Plückthun A
MAbs; 2017; 9(6):898-906. PubMed ID: 28621572
[TBL] [Abstract][Full Text] [Related]
3. Use of IMGT(®) databases and tools for antibody engineering and humanization.
Lefranc MP; Ehrenmann F; Ginestoux C; Giudicelli V; Duroux P
Methods Mol Biol; 2012; 907():3-37. PubMed ID: 22907343
[TBL] [Abstract][Full Text] [Related]
4. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
[TBL] [Abstract][Full Text] [Related]
5. How INNs are created. Making drug names safer by contributing to INN selection.
Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
[TBL] [Abstract][Full Text] [Related]
6. International Nonproprietary Names (INN) for pharmaceutical substances.
Kopp-Kubel S
Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
[TBL] [
